1 hour ago
2
Eli Lilly and Company (NYSE:LLY) is 1 of the Good Stocks to Buy Now. On March 20, Jefferies reiterated a Buy standing connected Eli Lilly and Company (NYSE:LLY) with a terms people of $1,300.
The standing is based connected the company’s medicine information for GLP-1 medications. Oral Wegovy had astir 89,300 IMS prescriptions and 76,800 Symphony prescriptions successful the 10th week of its launch. The information outpace comparable launches of injectable Wegovy and Zepbound.
On the different hand, information from different GLP-1 drugs witnessed declines, including Zepbound falling 3% to 17,100 prescriptions, Mounjaro dropping to 13,100 aft a 2% decline, and injectable Wegovy decreased 3% to 9,710.
The steadfast noted that the information for oral Wegovy is encouraging for Eli Lilly’s Orforglipron, up of its PDUFA day connected April 10, 2026. The steadfast projects $2 cardinal successful 2026 Orforglipron revenue, exceeding the $1.55 cardinal consensus, against Lilly’s guidance of $80 cardinal to $83 cardinal full revenue.
Eli Lilly and Company (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. These products span oncology, diabetes, immunology, neuroscience, and different therapies.
While we admit the imaginable of LLY arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 10 High-Flying Penny Stocks to Buy and 10 Cheap Stocks to Buy for High Returns successful 2026.
Disclosure: None. Follow Insider Monkey connected Google News.
.png)
English (CA) · 
English (US) · 
Spanish (MX) ·